MedTrace Logo

Interstitial Lung Disease in Early Rheumatoid Arthritis

NCT03977415 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2019-06-06

No results posted yet for this study

Summary

The purpose of this study is to determine how interstitial lung disease can be predicted over time in early rheumatoid arthritis. The investigators will study blood and phlegm samples from participants, along with quality of life questionnaires to determine if and how the presence of ILD may impact the participants quality of life over time.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joshua Solomon, MD · National Jewish Health

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-27
Primary Completion
2020-02-01
Completion
2021-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977415 on ClinicalTrials.gov